ATE509620T1 - Orale pharmazeutische zusammensetzung einer schwer wasserlöslichen wirksubstanz - Google Patents

Orale pharmazeutische zusammensetzung einer schwer wasserlöslichen wirksubstanz

Info

Publication number: ATE509620T1
Authority: AT; Austria
Prior art keywords: pharmaceutical composition; active substance; poorly water; oral pharmaceutical; soluble active
Prior art date: 2006-06-16

Application number

AT07730181T

Other languages

English (en)

Inventor

Henricus R M Gorissen

Original Assignee

Abbott Healthcare Products Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-16

Filing date

2007-06-15

Publication date

2011-06-15

2007-06-15 Application filed by Abbott Healthcare Products Bv filed Critical Abbott Healthcare Products Bv

2011-06-15 Application granted granted Critical

2011-06-15 Publication of ATE509620T1 publication Critical patent/ATE509620T1/de

Links

239000013543 active substance Substances 0.000 title 1
239000008203 oral pharmaceutical composition Substances 0.000 title 1
239000000203 mixture Substances 0.000 abstract 5
150000001875 compounds Chemical class 0.000 abstract 4
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 abstract 2
238000009472 formulation Methods 0.000 abstract 2
NTQSYIWTDXTRGG-UHFFFAOYSA-N 2-(1-benzazepin-1-yl)acetic acid Chemical group OC(=O)CN1C=CC=CC2=CC=CC=C12 NTQSYIWTDXTRGG-UHFFFAOYSA-N 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
229910000029 sodium carbonate Inorganic materials 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT07730181T 2006-06-16 2007-06-15 Orale pharmazeutische zusammensetzung einer schwer wasserlöslichen wirksubstanz ATE509620T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US81407606P	2006-06-16	2006-06-16
EP06115582		2006-06-16
PCT/EP2007/055937 WO2007144418A1 (en)	2006-06-16	2007-06-15	Oral pharmaceutical composition of a poorly water-soluble active substance

Publications (1)

Publication Number	Publication Date
ATE509620T1 true ATE509620T1 (de)	2011-06-15

Family

ID=38475902

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07730181T ATE509620T1 (de)	2006-06-16	2007-06-15	Orale pharmazeutische zusammensetzung einer schwer wasserlöslichen wirksubstanz

Country Status (10)

Country	Link
EP (1)	EP2034967B1 (de)
JP (1)	JP2009539940A (de)
KR (1)	KR20090032085A (de)
AT (1)	ATE509620T1 (de)
AU (1)	AU2007259252A1 (de)
CA (1)	CA2654111A1 (de)
EA (1)	EA014898B1 (de)
IL (1)	IL195531A0 (de)
NO (1)	NO20090163L (de)
WO (1)	WO2007144418A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2788289B1 (de) *	2011-12-09	2019-07-31	Merck Patent GmbH	Porenarmes, wasserfreies natriumcarbonat

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR038681A1 (es) *	2002-02-14	2005-01-26	Solvay Pharm Bv	Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
WO2004062692A1 (en) *	2003-01-13	2004-07-29	Solvay Pharmaceuticals B.V.	Formulation of poorly water-soluble active substances
TW200633713A (en) *	2004-12-23	2006-10-01	Solvay Pharm Bv	Oral immediate release formulation of a poorly water-soluble active substance
WO2007054975A1 (en) *	2005-11-08	2007-05-18	Panacea Biotec Ltd	Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders

2007
- 2007-06-15 WO PCT/EP2007/055937 patent/WO2007144418A1/en not_active Ceased
- 2007-06-15 AT AT07730181T patent/ATE509620T1/de not_active IP Right Cessation
- 2007-06-15 KR KR1020097000922A patent/KR20090032085A/ko not_active Withdrawn
- 2007-06-15 AU AU2007259252A patent/AU2007259252A1/en not_active Abandoned
- 2007-06-15 EP EP07730181A patent/EP2034967B1/de active Active
- 2007-06-15 EA EA200970020A patent/EA014898B1/ru not_active IP Right Cessation
- 2007-06-15 CA CA002654111A patent/CA2654111A1/en not_active Abandoned
- 2007-06-15 JP JP2009514807A patent/JP2009539940A/ja not_active Withdrawn
2008
- 2008-11-26 IL IL195531A patent/IL195531A0/en unknown
2009
- 2009-01-12 NO NO20090163A patent/NO20090163L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO20090163L (no)	2009-01-14
WO2007144418A1 (en)	2007-12-21
EP2034967A1 (de)	2009-03-18
CA2654111A1 (en)	2007-12-21
KR20090032085A (ko)	2009-03-31
EA014898B1 (ru)	2011-02-28
EP2034967B1 (de)	2011-05-18
IL195531A0 (en)	2009-09-01
EA200970020A1 (ru)	2009-06-30
AU2007259252A1 (en)	2007-12-21
JP2009539940A (ja)	2009-11-19

Similar Documents

Publication	Publication Date	Title
CL2007003491A1 (es)	2008-06-20	Forma cristalina del acido (3s)-3-[n-(n-(2-tercbutilfenil)oxamil)alaninil]amino-5(23,5,6-tetrafluorofenoxi)-4-oxopentanoico; composicion farmaceutica que comprende a dicho compuesto; y su uso para tratar la fibrosis hepatica.
PE20030638A1 (es)	2003-07-21	Formulacion granular de montelukast sodico
CR9626A (es)	2008-04-10	Formas de dosificacion de liberacion retardada oral altamente biodisponible de un o-desmetilvenlafaxin succinato
ES2721148T3 (es)	2019-07-29	Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel y métodos relacionados de preparación y uso
AR018109A1 (es)	2001-10-31	FORMULACIoN GALÉNICA ADMINISTRABLE POR VíA ORAL QUE PERMITE UNA ABSORCIoN MEJORADA DE PRINCIPIOS ACTIVOS, USO DE UN AGENTE MAJORADOR DE ABSORCIoN PARA PREPARAR UNA FORMA DE DOSIFICACIoN ADMINISTRABLE POR VíA ORAL Y PROCEDIMIENTO PARA PREPARAR DICHA FORMULACIoN GALÉNICA
ATE337793T1 (de)	2006-09-15	Dispergierbare pharmazeutische zusammensetzung eines entzündungshemmers
AR068369A1 (es)	2009-11-11	Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina"
ATE518534T1 (de)	2011-08-15	Stabile orale pharmazeutische zusammensetzung mit thyroidhormonrezeptoragonisten
CL2008000134A1 (es)	2008-05-16	Compuesto 5-[4-(2 metil fenil)-3-hidroxi-4h-[1,2,4] triazol-5-il]-2,4-dihidroxi n metil n butil benzamida; composicion farmaceutica que contiene a dicho compuesto; kit farmaceutico que contiene a dicho compuesto; y su uso para tratar cancer, enfermed
UY30610A1 (es)	2008-05-02	Moduladores de mglur5
ATE522204T1 (de)	2011-09-15	Beschichtete pellets
DE60022188D1 (de)	2005-09-29	Amorphe salpetersäureester und deren pharmazeutische zusammensetzungen
UY31403A1 (es)	2009-05-29	"derivados novedosos de ({((3-metilfenil)-2h-tetrazol-5-il)-etoxi} -4h-1,2,4-triazol-3-il), composiciones farmacéuticas conteniendolos y uso médico de los mismos".
BR0307278A (pt)	2004-12-28	Formulação oral de liberação imediata, e, método para preparar uma formulação
YU59201A (sh)	2004-07-15	Matrica koja se može direktno komprimovati, za kontrolisano oslobadjanje pojedinačnih dnevnih doza klaritromicina
ECSP11011286A (es)	2011-09-30	Formulaciones orales sólidas de una pirido-pirimidinona
PA8586301A1 (es)	2004-05-07	Formulaciones de liberacion prolongada en forma de suspension
ITMI20062286A1 (it)	2008-05-29	Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi
ATE388695T1 (de)	2008-03-15	Pharmazeutische zusammensetzung enthaltend ein benzimidazol-derivat gemischt mit mikrokristalliner cellulose
WO2007022023A3 (en)	2007-05-31	Film forming spreading agents
NO20044723L (no)	2004-11-01	Injiserbare veterinaermedisinske sammensetninger for sma dyr
BRPI0815531A2 (pt)	2015-02-10	"compostos, composição farmacêutica, composição cosmética, uso cosmético de uma composição e uso de um composto"
NO20090163L (no)	2009-01-14	Kombinasjonsfremstillinger innbefattende en darlig vannopploselig aktiv substans
UA90700C2 (ru)	2010-05-25	Оральная композиция немедленного выделения на основе слабоводорастворимого действующего вещества
BRPI0607811A2 (pt)	2009-10-06	derivados de óxido de pirimidina de 2-(4-cianofenilamino) inibidores de hiv, composição farmacêutica compreendendo os mesmo, processo para preparar a referida composição e uso

Legal Events

Date	Code	Title	Description
2011-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties